chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Clt. came in on 08/21/2007 for routine immunizations. She was given Var and hep A. MOC reported that child had bad rxn to DTP shots previously and she was worried that her other children would have rxns to vaccines. Since this child was not receiving a vaccine with pertussis in it the mom was not concerened about her having a rxn. The vaccines were given and the next morning the mom called wondering which vaccine was given in the Right Arm. When I spoke to the MOC she reported that her child's arm had done what it had when she received a vaccine containg pertussis that it was red and swollen and hot to the touch. MOC was told by the school that she had a fever but when mom took her temp it was 98.6. Child did not feel well, tired and achey. Tylenol was given for aches and fever and cold compresses were used on injection site.
Presented after syncopal episode, prior to event had weakness. Covid + tx w/ Dexamethasone, Vit D/C and zinc
Saw doctor for a physical on 10/1. He recommended Tdap I woke up at 2;30am 10/2 to use the restroom I started shaking uncontrollably and blacked out. I fell face forward onto the tile floor. I had to go to the ER and required 8 stitches on my face. I also developed a fever on 10/2 up to 103 and an still experiencing mild fever as of 10/4. My bloodwork from my physical shows that I am completely healthy so the vaccine caused my reaction.
The patient experienced immediate swelling at the site of the injection followed by urticaria on the chest and leg.
2 periods in a month  Dizziness  Heart palpitations  Tachycardia
Patient stated - that after thigh vaccine (TDAP) he developed a high fever - and generalized rash. States took Benadryl & Tylenol helped symptoms - Denied difficulty breathing.
Information has been received from 2 healthcare workers referring to a patient of unknown age and gender. The patient's medical history was not reported. On 23-FEB-2015, the patient was received improperly stored VARIVAX (Merck) (lot # K007979, exp date 03-JUN-2016, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
pt recvd vax & w/in 24 hrs pf vax exp lump the size of a fifty cent piece, redness & itching; p/10 days the size of the lump had dec somewhat;
shingles in my ear / Ramsey Hunt syndrome; had shingles 10 days after the first innoculation; This case was reported by a consumer via media and described the occurrence of ramsay-hunt syndrome in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 10 days after receiving Shingles vaccine, the patient experienced ramsay-hunt syndrome (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the ramsay-hunt syndrome was not recovered/not resolved and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the ramsay-hunt syndrome and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient too had the shingles 10 days after the 1st inoculation of Shingles vaccine. The patient woke up with shingles in his/her ear and Ramsey Hunt syndrome. It was a long 5 months before the patient healed in the ear. The patient still had residual issues from the Ramsey Hunt syndrome. The patient would still recommend the Shingles shot be taken.
Within three weeks of a herpes zoster vaccination, patient suffered binocular diplopia involving right cranial nerve palsy and severe periorbital pain around the right eye. Extensive tests eliminated other causes for this adverse event.
Patient notified health facility about a large, red area on her left arm that was hard, and warm to touch that appeared on the 8th day after receiving her 1st COVID-19 vaccine.   Patient stated that the area went away after a few days.  Patient was previously diagnosed with COVID-19 and it was lab confirmed.
Patient states got a tetanus shot at health services 4 days ago.  Now has elevated temperature, swollen left arm since that time.  Diagnosis:  Erythema to reaction.  No temperature.  Treated with cream, cold compress, and Motrin.
No other AE reported; patient received PROQUAD off schedule/ she received PROQUAD at 12 months of age and 25 months of age.; This spontaneous report was received from a physician referring to a 25 months old (currently 4-year-old) female patient. The patient's concomitant medication, pertinent medical history and drug reactions and allergies were not provided.  In 2018 (reported as at 12 months of age) and in 2020 (reported as in 25 months of age), the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (dose, strength, route, lot# and expiration date were not provided) respectively for prophylaxis (inappropriate schedule of product administration). No other adverse event (AE) was reported. It was unknown if treatment was given. It was unknown if lab diagnostics and studies were performed. It was unknown if medical attention was sought.
Information has been received from a 74 year old male consumer with no known allergies who on 12-JUN-2007 was vaccinated with a dose of Zostavax (Oka/Merck).  Concomitant therapy included ezetimibe + simvastatin (MSD), aspirin, LOPRESSOR and MAXZIDE.  On 19-JUN-2007 (a week after the vaccination) the patient developed shingles.  Unspecified medical attention was sought.  No lab studies were performed.  At the time of this report the patient had not recovered.  No further information was provided.  There was no product quality complaint involved.  Additional information has been requested. This is in follow-up to report (S) previously submitted 5/24/2007: 12/21/2007. Information has been received from a 74 year old male consumer with no known allergies who on 12-JUN-2007 was vaccinated with a dose of ZOSTER vaccine live (Oka/Merck).  On 19-JUN-2007 (a week after vaccination) the patient developed shingles. Unspecified medical attention was sought. No lab studies were performed. At the time of this report the patient had not recovered. No further information was provided. There was no product quality complaint involved. In follow-up information received from the physician, it was reported that the patient was vaccinated on 12-JUN-2007 at 10:14 AM with a dose of ZOSTER vaccine live (Oka/Merck) (656008/0032U), SC in left arm. There was no illness at the time of vaccination. The physician reported that the patient is now under treatment for post herpetic neuralgia. In follow-up information received from the physcian. it was reported that the patient continued to experience post herpetic neuralgia chronic pain. Additional information has been requested.
19 cm x 19 cm area of redness on (R) thigh, warm, non tender. Cellulitis,
pt recv vax 4FEB97 & 7FEB97 pt exp swelling & tenderness of rt hand & arthritic pain in rt middle finger;pt noted a burning sensation when exposed to cold & the skin on rt hand was darker;tx w/Motrin & Medrol;
No additional AE's.; Caller stated that the GARDASIL 9 was administered on the same day as the excursion to one patient; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent concurrent conditions, medical history, concomitant medications and previous drug reactions or allergies were not provided.   On 01-APR-2021, the patient was vaccinated with and improperly store hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) as prophylaxis (concentration, number of dose administered, dosage, vaccination scheme frequency, route of administration and anatomical location were not reported; lot number S023476 and expiration date 26-MAR-2022). No adverse events were reported for the patient.  According to the reporter, the temperature excursion was 36 degrees Fahrenheit to 46 degrees Fahrenheit (48 degrees Fahrenheit) for a time frame of 1 hour and 35 minutes and above 47 degrees Fahrenheit (48. degrees Fahrenheit) for 3 hours 35 minutes on 01-APR-2021 (product storage error), without any previous temperature excursion, which was detected by a digital data logger.  combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S023476; expirationdate: 26-MAR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Mother refers he became lethargic and eyes turned to left side; became limp for 10 seconds. This happened approximately 6 hours after immunization.
This  84  year old   male was a hospice patient and received the Covid shot on  2/24/21 .  The patient died on  4/1/21.  Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.
Patient reported feeling as if she was about to faint. Patient reported no shortness of breath and breathing was normal at the time.  Suddenly patient lost consciousness, face turned red, tremor, seizure-like activity, sweating,  vomiting, and trouble breathing occurred. Healthcare workers then called 911 and were preparing Epi pen to administer. Right before administration of epi pen patient regained consciousness and reported feeling back to normal.  Patient was monitored closely for other signs of trouble breathing but patient reported feeling better and stable. First responders arrived at the scene. First responders took patients vital signs. Patients blood pressure, pulse, and oxygen were all in normal range.
Numbness, weakness, and pain in right arm. Later reported of increased redness and swelling in hand, itchy all over, heavy arm, and rash around neck.
R facial pain jaw and cheek. Pain starting mild on Fri morning progressing to severe pain on Sat night slightly improving with tylenol and motrin.  Pain not improving, Dr appt on 9/15 and diagnosed with trigeminal neuralgia.  Started on tegretol 100mg 2 times a day increasing dose until pain improved to current dose of 300mg 3 times a day. Still requiring tylenol and motrin for break through pain.
45-60 Minutes post vaccination, trembling, confusion, nausea, light headness & dizziness, generalized itching but no rash, slight fever.  Contacted my Asthma Specialist.  Home, developed chest pain which localized to left neck & shoulder. swelling @ left sternal area, tachycardia, hoarsness , headache & blurred vision. Asthma doctor encouraged me to see PCP.  As already late in day, saw PCP following day.  Did EKG which was WNL.  Told to return for Stress Test should chest pain return.
On the sixth day after vaccination I began to feel itching at vaccination site. It continued into the 7th day when a red area began to form around the vaccination site. The redness spread to about 1-2 inches around for another day and then began to subside.
11/22/99, Mom called & said pt had 2-3 "mosquito like" spots on the back of her legs last night. Mom thought they were bug bites, but when she returned home from school today, she had 10 spots on her abdomen, legs & face with itching.
Developed slight fever of 101 the day after the second dose of the vaccine. The following two days were lead by extreme fatigue, headache, and shortness of breath.
tired; brain fog; general flu like symptoms; This is a spontaneous report from a non-contactable other hcp (patient) via Pfizer sales representative. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported) as dose 1, single and on 04Feb2021 as dose 2, single both via an unspecified route of administration on an unspecified date for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date patient experienced tired, brain fog, general flu like symptoms following first dose of vaccine. On second dose she also had these same like symptoms. She received second dose on 04Feb and is symptom free as of today. The outcome of the events was recovered an unspecified date in Feb2021.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Patient received first dose of COVID-19 vaccine at 1233 and tolerated procedure well. Approx. two minutes later patient asked for some water and RN asked another nurse to bring the patient some water. In the mean time patient began to complain of "pain in ears" then passed out for approx. 20 seconds. RN laid the patient on the floor with the help of her father. Staff placed an ice pack on the back of her neck and elevated her feet at this time as well. Patient became alert with verbal stimuli. RN took vitals at 1239 with patient supine (B/P -78/50, pulse - 62 bpm, SPO2 - 97%). Patient was sweating but said she felt better. At 1244 staff helped patient to a seated position and re-took vitals (B/P - 80/62, pulse - 72 bpm, SPO2 - 99%). At 1251 a final set of vitals were taken which were (B/P - 88/66, pulse - 77 bpm, SPO2 - 99%). RN continued to observe patient until she left the building at 1306.
Patient reported hives, swollen eyes and vomiting about 1 hour after Moderna dose was given.   States that symptoms lasted over 24 hours before resolving.
24 hours after vaccination I spiked a 101.4 fever and it has not resolved 48 hours after the vaccine. My head is pounding. I feel weak and I find it hard to stand up for very long
After explaining side effects, patient received 1st dose of SHINGRIX vaccine at approx. 2:15pm. She left shortly after and was told to call if she has a reaction other than sore arm/site redness. She returned approx. 2:32pm, stating that about 10 mins after the vaccine, her throat started to feel constricted (similar to her reaction to contrast dye in the past), but stated she didn't have trouble breathing or lightheadedness. She agreed to diphenhydramine and I gave her 50mg (20ml x 12.5mg/ml). After about 5 minutes I checked in with her and she stated that the constriction was not as severe and she could tell it was getting better at 2:41pm. I asked where she was at mentally as far as feeling comfortable leaving or wanting to stick around for a while longer; she said she was comfortable leaving and did so at 2:45pm. I called her physician's office and explained the situation with the nurse at 4:04pm.
Swollen gland in neck still there after almost 4 weeks; This is a spontaneous report from a contactable healthcare professional. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0162) via an unspecified route of administration in the arm left on 18May2021 at 10:15(at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the arm left on an unknown date in Apr2021 at 10:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19May2021, the patient experienced swollen gland in neck still there after almost 4 weeks. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of this event. The clinical outcome of the event swollen gland in neck still there after almost 4 weeks was not recovered at the time of this report.
joint pain, fevers/chills, nausea, and fatigue lasting 24 hours Narrative:
Information has been received from a nurse concerning a 52 year old caucasian female who, in the evening, on 10/18/2004 was vaccinated intramuscularly in the left deltoid with a 0.5ml second dose of pneumococcal 23v polysaccharide vaccine (lot 649696/0490P).  3 to 4 days post vaccination the patient had severe reactions to the vaccine, with the development of chills; fever; trembling; numbness; tingling, redness and swelling (also reported that there was no redness or swelling) in the vaccinated limb; and nerve pain down her arm about 2 inches from the injection site.  The patient also lost some range of motion in the vaccinated arm.  Unspecified medical attention was sought.  The patient's outcome was not reported.  Follow up information from a registered nurse indicated that, in the evening, on 10/18/2004 the patient developed myalgia, severe pain from her wrist to shoulder and she was unable to use her arm.  It was noted that the patient missed one day of work on 10/19/2004.  It was reported that the patient recovered from myalgia, pain from wrist to shoulder and unable to use arm on 10/21/2004.  The records of testing prior to release of this lot have been checked and found to be satisfactory.  The lot complies with industry standards and was released.  It was also reported that 3 other patients had adverse experiences following administration of pneumococcal 23v polysaccharide vaccine.  Additional information has been requested.
Soreness on the arm where shot administered. Notice it a couple days after, still sore issues raising arm back or putting sweater on. Tried TYLENOL no relief.
MISSED HIS LAST DOSE AND TOOK IT IN THE MORNING; This spontaneous case report (PVX2019-1694) was received from a healthcare professional on 28-Jun-2019. It describes a male consumer who "missed his last dose and took it in the morning" (Inappropriate schedule of vaccine administered). She was receiving Vivotif for an unknown indication.  Case report: The consumer missed his last dose of Vivotif and took it the next morning. She did not know the dates on which Vivotif was taken.    Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed his last dose and took it in the morning" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed his last dose and took it in the morning" was considered as not applicable.
About 4 hours after vaccination the baby had become very fussy, irritated, excessively crying, did not sleep or ate well. I was advised by a nurse not to give infant's Tylenol as it would decrease vaccine respond. When questioned Dr. of safety of vaccines she ignorantly laughed.
MISERABLE AT FIRST; NO APPETITE; RED LIKE YEAST INFECTION UNDER BREAST; RED LIKE YEAST INFECTION UNDER BREAST; RASH UNDER THE BREAST; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Apr-2021 and was forwarded to Moderna on 03-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (MISERABLE AT FIRST), DECREASED APPETITE (NO APPETITE), FUNGAL INFECTION (RED LIKE YEAST INFECTION UNDER BREAST), ERYTHEMA (RED LIKE YEAST INFECTION UNDER BREAST) and RASH (RASH UNDER THE BREAST) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced FEELING ABNORMAL (MISERABLE AT FIRST), DECREASED APPETITE (NO APPETITE), FUNGAL INFECTION (RED LIKE YEAST INFECTION UNDER BREAST), ERYTHEMA (RED LIKE YEAST INFECTION UNDER BREAST) and RASH (RASH UNDER THE BREAST). At the time of the report, FEELING ABNORMAL (MISERABLE AT FIRST), DECREASED APPETITE (NO APPETITE), FUNGAL INFECTION (RED LIKE YEAST INFECTION UNDER BREAST), ERYTHEMA (RED LIKE YEAST INFECTION UNDER BREAST) and RASH (RASH UNDER THE BREAST) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 03-Apr-2021: No specific follow-up information recorded.
Patient was admitted to the emergency room the morning after receiving the vaccine and died on 07Apr2021; Nasal swab Positive; This is a spontaneous report from a contactable consumer. An 86-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 30Mar2021 (Batch/Lot number was not reported) (at the age of 86 years old) as single dose for COVID-19 immunization. Medical history included gastro-intestinal problem. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. No other vaccine in four weeks. No COVID prior vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was admitted to the emergency room on 31Mar2021 the morning after receiving the vaccine. The patient was hospitalized for two days. It was unknown if treatment was given. This event (Patient was admitted to the emergency room the morning after receiving the vaccine and died on 07Apr2021) resulted in emergency room/department or urgent care, hospitalization and life threatening illness (immediate risk of death from the event) and patient died. The patient died on 07Apr2021. The patient's nasal swab was positive on 31Mar2021. The outcome of the event nasal swab was positive was unknown. It was not reported if an autopsy was performed.  Information on batch/lot number has been requested.; Reported Cause(s) of Death: Patient was admitted to the emergency room the morning after receiving the vaccine and died on 07Apr2021
Playing basketball, I experienced an allergic reaction, which I had never had before. I went into anaphylaxis and experienced hives and facial swelling.
After receiving my first shot, I sat in the waiting room. My tongue started feeling somewhat funny, my whole body felt very warm, I had some pain in my abdomen on the left side (the side I had the shot), facial flushing, dizziness, headache. I was checked out by the medical staff at 11:25, they determined that I was probably safe to go home. On the way out, I developed itchy lips and hives on my upper lip. The dizziness lasted three days, and was accompanied by severe chills. I took Benadryl after a very nervous ride home. Everything up to the dizziness subsided.
I contracted covid which upset my asthma and  caused G.I upset and fatigue. Insomnia